CVS241220C47000
- 0.03
- -0.05-62.50%
CVS Health Newsroom
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $80
Why CVS Health (CVS) Outpaced the Stock Market Today
Express News | Varo Bank Introduces Zero Fee Cash Deposits at Participating CVS Locations
CVS Health: Strategic Buy Rating Amidst Industry Reforms and Valuation Opportunities
Why CVS Health (CVS) Is the Best Dividend Leader to Buy According to Wall Street Analysts?
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
CVS Health Has Strong Position in DOJ Case, Says TD Cowen
CVS Health Options Spot-On: On December 19th, 133.75K Contracts Were Traded, With 900.53K Open Interest
U.S. Healthcare Spending Climbs 7.5% in 2023
Moody's Policy Shift Fuels Hybrid Bond Growth Across Key U.S. Sectors
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Baird Adjusts CVS Health Price Target to $51 From $61, Maintains Neutral Rating
Peering Into CVS Health's Recent Short Interest
Wells Fargo Trim Price Target on CVS Health to $65 From $66
Reasons to Ratain CVS Stock in Your Portfolio Now
PBM Reform Looks Manageable for CVS Health, Says UBS
Stock Market's Fed Reaction Is Overdone. But New -2-
Leerink Partners Maintains CVS Health(CVS.US) With Hold Rating, Cuts Target Price to $51
CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions
Aetna Adds Spanish Language Capabilities for Health App to Better Serve Diverse Populations